The study finds that elevated TRIM69 serves as a bioindicator for disease progression in systemic lupus erythematosus, suggesting clinical implications.
The study suggested that the elevated TRIM69 may play a role in SLE pathogenesis and predictive model based on serum TRIM69 levels, HGB, and NLR act as bioindicator for forecast and progression of diseases.
No takes yet. Share an insight, caveat, or question.
Zhan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: